Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

Non-Steroidal Anti-Inflammatory Drugs

Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used to alleviate pain, inflammation, swelling, and fever through inhibition of cyclooxygenase enzymes COX-1 and COX-2. Beyond their well-established analgesic, anti-inflammatory, and antipyretic actions, certain NSAIDs—including Acetylsalicylic Acid (Aspirin, A118582 suitable for plant cell culture ≥99%, A104180 ≥99%) and Piroxicam (P129294 ≥98%, P407766 10mM in DMSO)—have demonstrated chemopreventive properties, reducing the risk of several cancers such as colorectal, breast, intestinal, and prostate cancers. These protective effects are mediated by both COX-dependent and COX-independent pathways.


Mechanisms of Chemoprevention: Inhibition of COX enzymes increases intracellular levels of arachidonic acid, a prostaglandin precursor. In colon cancer cells, elevated arachidonic acid promotes the conversion of sphingomyelin to ceramide, leading to apoptosis. Animal studies of colorectal cancer corroborate this mechanism; administration of Sulindac (S125148 ≥98%, S408587 10mM in DMSO) induces apoptosis and suppresses the development of aberrant crypt foci.


NSAIDs also exert chemopreventive effects by targeting phosphodiesterase 5 (PDE5). Inhibition of PDE5 raises intracellular cGMP, which activates protein kinase G (PKG). This cascade subsequently triggers JNK1 activation and downregulation of β-catenin–mediated transcription, culminating in cell cycle arrest, apoptosis induction, and reduced angiogenesis. Compounds such as Sulindac and Flurbiprofen (F134483 ≥98%, F408049 10mM in DMSO) act via this pathway, effectively suppressing cancer development in cellular models.


Aladdin provides an extensive portfolio of NSAIDs for research, including:

· Non-selective COX inhibitors

· COX-2 selective inhibitors such as Etoricoxib (E126660 ≥98%, E422460 10mM in DMSO), Meloxicam (M129228 ≥98%, M408223 10mM in DMSO), and Celecoxib (C129279 ≥99%, C408187 10mM in DMSO,  C1372189-GMP)

· And many additional compounds supporting cancer, inflammation, and cell signaling studies.



References:

1. Vainio H, Morgan G. Scand J Gastroenterol. 1998 Aug;33(8):785-9.

2. Schmitz-Drager BJ, Schoffski O, Marberger M, et al. Recent Results Cancer Res. 2014;202:79-91.

3. Harris RE, Kasbari S, Farrar WB. Oncol Rep. 1999 JanFeb;6(1):71-3.

4. Ritland SR, Gendler SJ. Carcinogenesis. 1999 Jan;20(1):51-8.

5. Chan TA, Morin PJ, Vogelstein B, et al. Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):681-6.

6. Martin JE, Le Leu RK, Hu Y, et al. Am J Physiol Gastrointest Liver Physiol. 2010 Jun;298(6):G860-4.

7. Gurpinar E, Grizzle WE, Piazza GA. Front Oncol. 2013 Jul 11;3:181.

8. Nath N, Liu X, Jacobs L, et al. Drug Des Devel Ther. 2013 May 6;7:389-96.​

 

Aladdin: https://www.aladdinsci.com/

Categories: Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Cite this article

Aladdin Scientific. "Non-Steroidal Anti-Inflammatory Drugs" Aladdin Knowledge Base, updated 19 set 2025. https://www.aladdinsci.com/eu_it/faqs/non-steroidal-anti-inflammatory-drugs-en.html
Was this article helpful? Yes No 39 out of 74 found this helpful

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.